Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 322,038 shares at $145.43 ($49.6M) on 2020-12-07, disclosed to the SEC on 2020-12-09.
Open-market sale of $49.6M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $144.39 | 4,809 | $694K | 1.4% |
| 2 | $144.39 | 4,809 | $694K | 1.4% |
| 3 | $145.43 | 2,762 | $402K | 0.8% |
| 4 | $145.43 | 2,762 | $402K | 0.8% |
| 5 | $146.57 | 4,203 | $616K | 1.2% |
| 6 | $146.57 | 4,203 |
| $616K |
| 1.2% |
| 7 | $147.40 | 24,077 | $3.5M | 7.1% |
| 8 | $147.40 | 24,077 | $3.5M | 7.1% |
| 9 | $148.45 | 12,703 | $1.9M | 3.8% |
| 10 | $148.45 | 12,703 | $1.9M | 3.8% |
| 11 | $149.41 | 9,416 | $1.4M | 2.8% |
| 12 | $149.41 | 9,416 | $1.4M | 2.8% |
| 13 | $150.57 | 7,067 | $1.1M | 2.1% |
| 14 | $150.57 | 7,067 | $1.1M | 2.1% |
| 15 | $151.32 | 600 | $91K | 0.2% |
| 16 | $153.44 | 10,098 | $1.5M | 3.1% |
| 17 | $153.44 | 10,098 | $1.5M | 3.1% |
| 18 | $154.41 | 4,300 | $664K | 1.3% |
| 19 | $155.36 | 12,123 | $1.9M | 3.8% |
| 20 | $155.36 | 12,123 | $1.9M | 3.8% |
| 21 | $156.53 | 4,457 | $698K | 1.4% |
| 22 | $156.53 | 4,457 | $698K | 1.4% |
| 23 | $157.54 | 8,582 | $1.4M | 2.7% |
| 24 | $157.54 | 8,582 | $1.4M | 2.7% |
| 25 | $158.41 | 15,260 | $2.4M | 4.9% |
| 26 | $158.41 | 15,260 | $2.4M | 4.9% |
| 27 | $159.48 | 8,453 | $1.3M | 2.7% |
| 28 | $159.48 | 8,453 | $1.3M | 2.7% |
| 29 | $160.50 | 9,397 | $1.5M | 3.0% |
| 30 | $160.50 | 9,397 | $1.5M | 3.0% |
| 31 | $161.57 | 17,627 | $2.8M | 5.7% |
| 32 | $161.57 | 17,627 | $2.8M | 5.7% |
| 33 | $162.40 | 14,270 | $2.3M | 4.7% |
| 34 | $163.13 | 800 | $131K | 0.3% |
| Total | $154.16 avg | 322,038 | $49.6M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |